Literature DB >> 15837730

Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.

Nadia Zaffaroni1, Raffaella Villa, Ugo Pastorino, Rosalia Cirincione, Matteo Incarbone, Marco Alloisio, Maria Curto, Silvana Pilotti, Maria Grazia Daidone.   

Abstract

PURPOSE: Preliminary evidence indicates that telomerase activity is significantly less expressed in typical carcinoids than in large cell neuroendocrine carcinomas or in small cell lung cancers. Knowledge of the mechanisms by which telomerase is differentially regulated in neuroendocrine lung tumors is important for a better understanding of the pathogenesis of these malignancies. EXPERIMENTAL
DESIGN: We investigated telomerase activity in 86 neuroendocrine lung tumors and correlated the enzyme activity with the expression of the enzyme subunits [human RNA component (hTR), human telomerase reverse transcriptase (hTERT), and alternatively spliced hTERT variants], with the telomere-associated protein human protection of telomere-1, and with the telomere length pattern.
RESULTS: A significantly (P = 0.0001) lower frequency of telomerase-positive cases was found in typical carcinoids (14%) than in large cell neuroendocrine carcinomas (87%) and small cell lung cancers (92%). hTR was constitutively expressed in all carcinoids. Telomerase-negative carcinoids were characterized by the absence of any hTERT transcript, only displayed the beta(-) alternatively spliced variant, or concomitantly expressed the alpha(+)beta(+) full-length message with different combinations of alternatively spliced variants. However, in these tumors, a more abundant level of alternatively spliced transcripts than that of the alpha(+)beta(+) full-length transcript was generally found. No significant difference was observed in human protection of telomere-1 expression between telomerase-negative and telomerase-positive carcinoids. Telomeres were significantly (P < 0.05) longer in telomerase-negative carcinoids than in telomerase-positive carcinoids (median value, 9.15 versus 4.47 kb). However, alternative lengthening of telomeres, as shown by associated promyelocytic leukemia bodies, was not observed in these tumors.
CONCLUSIONS: Our results indicate that telomerase is repressed in most lung carcinoids and that hTERT transcription and alternative splicing play a role in such a negative regulation. Moreover, the absence of any telomerase maintenance mechanism may contribute to the favorable prognosis of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837730     DOI: 10.1158/1078-0432.CCR-04-1293

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  8 in total

1.  Expression of T-STAR gene is associated with regulation of telomerase activity in human colon cancer cell line HCT-116.

Authors:  Ling Zhang; Lian Guo; Yong Peng; Bing Chen
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.

Authors:  Lisa F Lincz; Lisa-Maree Mudge; Fiona E Scorgie; Jennette A Sakoff; Christopher S Hamilton; Michael Seldon
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

Review 3.  Telomerase and the endocrine system.

Authors:  Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

4.  Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.

Authors:  Christopher M Heaphy; Michael C Haffner; Mindy K Graham; David Lim; Christine Davis; Eva Corey; Jonathan I Epstein; Mario A Eisenberger; Hao Wang; Angelo M De Marzo; Alan K Meeker; Tamara L Lotan
Journal:  Hum Pathol       Date:  2020-05-07       Impact factor: 3.466

Review 5.  Genes involved in neuroendocrine tumor biology.

Authors:  Eva Hofsli
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 6.  Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.

Authors:  Luisella Righi; Marco Volante; Ida Rapa; Giorgio V Scagliotti; Mauro Papotti
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

Review 7.  Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Authors:  Nivedita Basu; Halcyon G Skinner; Kristin Litzelman; Russell Vanderboom; Esha Baichoo; Lisa A Boardman
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11       Impact factor: 3.869

Review 8.  Human telomerase activity regulation.

Authors:  Aneta Wojtyla; Marta Gladych; Blazej Rubis
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.